In non-small cell lung cancer, miR-206 decreased hepatocyte growth factor (HGF)-induced cell EMT and angiogenesis by targetting c-MET/PI3K/AKT/mTOR pathway [26]. The gene discussed is HGF; the disease is non-small cell lung carcinoma.